Wikipedia

Mamun Al Mahtab

Mamun Al Mahtab (nickname: Shwapnil; born 22 August 1970) is a Bangladeshi doctor, hepatologist, medical scientist, and author. With 290 publications in national and international peer-reviewed journals to his credit, Mahtab works as the Head, Division of Interventional Hepatology, Bangabandhu Sheikh Mujib Medical University (BSMMU).

Mamun Al Mahtab
Head and shoulders photo of Mamun Al Mahtab
Al Mahtab in 2021
Born (1970-08-22) August 22, 1970 (age 54)
Bangladesh
Occupation(s)Divisional Head, Interventional Hepatology Division, Bangabandhu Sheikh Mujib Medical University

Lawsuits

edit

He has been subject to accusations and lawsuits of medical malpractice and negligence that led to patients' deaths.[1][2]

In May 2021, a Dhaka court ordered an investigation into allegations of negligence against three doctors, including Dr. Mamun Al Mahtab, leading to the death of another physician, Dr. Toufiq Enam. Physiotherapist Aktaruzzaman Mia filed a case with the Chief Metropolitan Magistrate's Court regarding the death of his son, Dr. Enam, on May 30 while undergoing treatment at BRB Hospital. Dr. Mahtab, a gastroenterologist at Labaid Hospital, was one of the three accused doctors. According to the allegations, Dr. Mahtab conducted an endoscopic retrograde cholangiopancreatography (ERCP) procedure on Dr. Enam after he developed complications following a surgery at Islami Bank Hospital. Dr. Mahtab admitted to treating Dr. Enam for hepatitis B and performing the ERCP with the patient's consent to avoid further surgery's high costs and risks. However, Dr. Enam's condition deteriorated, and he was transferred to BRB Hospital, where he passed away during an operation. Dr. Mahtab denied any negligence, claiming he was unaware of Dr. Enam's pre-existing conditions.[3][4]

Bio

edit

Mahtab is the chief researcher, and investigator for the GBPD060 clinical study of the Bangladesh-developed SARS-CoV-2 mRNA candidate. He is also the lead researcher on NASVAC's Phase I/II and III clinical studies.[5] Mahtab was jointly awarded the 'Premio Nacional' from the Cuban Academy of Sciences for the discovery of NASVAC[6] in 2019. He organizes awareness-raising programs on liver diseases across the country in addition to inventing the NASVAC[6] drug aiming to offer an effective solution to Hepatitis B at an affordable price for mass people in Bangladesh.

Education

edit

Mahtab graduated from Mymensingh Medical College in 1995. He was awarded an MSc in Gastroenterology from the University of London in 1998 and was subsequently awarded an MD in Hepatology at Bangabandhu Sheikh Mujib Medical University in 2006. He is a Fellow of the Royal College of Physicians of London, the Royal College of Physicians of Ireland, the Indian College of Physicians and the American College of Gastroenterology.[citation needed]

Career

edit

Mahtab is currently working as the Head, Division of Interventional Hepatology, Bangabandhu Sheikh Mujib Medical University (BSMMU).[7]

He is currently associated with Anwer Khan Modern Hospital Limited, Dhaka[8] and Labaid Specialized Hospital, Dhanmondi.[9] He also serves at Anwer Khan Modern Medical College Hospital as a Specialist Hepatologist & Gastroenterologist and at Labaid Specialized Hospital, Dhanmondi as a Liver & Liver Cancer Specialist & Interventional Endoscopist Divisional Head.[7]

Research

edit

Mahtab is the principal investigator of the phase I/II and III clinical trials of NASVAC,[10][11][12][13] a new generic for chronic hepatitis B, which is already registered in Bangladesh, Cuba, Nicaragua, Ecuador, Belarus and Angola. It is the first drug to be developed and registered in Bangladesh. NASVAC is also the 'first novel molecule' to be registered by the Directorate General of Drug Administration of the Bangladesh Government.[14]

Publications

edit

Mahtab has compiled six books, namely 'Liver: A Complete Book on Hepato-Pancreato-Biliary Diseases', published by Elsevier (2009),[15] 'Comprehensive Text Book on Hepatitis B', published by Jaypee (2010), 'Fatty Liver Disease' (2012) and 'Hepatitis Management Update' (2015) published by McMillan and 'Text Book of Hepato-Gastroenterology' (2015) and 'Practical Hepato-Gastroenterology Prescriber' (2016) published by Jaypee.[16]

Mahtab is serving on the Editorial Boards of several international journals in the fields of Hepatology and Gastroenterology including,

  • Euro-Asian Journal of Hepato-Gastroenterology (Journal of Euro-Asian Gastroenterological Association) (Co-Editor-in-Chief),[17]
  • Hepatology International (journal of Asian Pacific Association for the Study of the Liver) (Associate Editor)[18]
  • Journal of Clinical, Experimental Hepatology (journal of Indian Association for the Study of the Liver) (Editorial Board Member),[19]
  • Hepatitis B Annual (Kalinga Gastroenterology Foundation, India) (Co-Editor-in-Chief)[20] to name a few.

Affiliations

edit

He is four times elected Secretary General of Association for the Study of the Liver Diseases Bangladesh (ASLDB) (the national Hepatology Association of Bangladesh).[21] He is also foundering President of Bangabandhu Sheikh Mujib Medical University Hepatology Alumni Association[22] and Executive Chairman of Forum for the Study of the Liver Bangladesh.[23]

He is the founder General Secretary of Bangladesh Stem Cell and Regenerative Medicine Society.[24]

He has organized several 'first time in Bangladesh' medical conferences including the first STEMCON in 2017 (1st international conference on stem cell therapy in Bangladesh) and first EndoVasculoCon in 2019 (1st live conference from endoscopy suit and vascular lab in the region).[25]

He is Member Secretary of Sampritee Bangladesh.[26]

References

edit
  1. ^ "Where is the accountability in Bangladesh's healthcare?". Dhaka Tribune. Retrieved 2024-04-17.
  2. ^ Death after endoscopy: Family alleges negligence, doctor blames missing records (dhakatribune.com)
  3. ^ "Three doctors charged with negligence in the death of another physician". bdnews24.com. Retrieved 2024-02-22.
  4. ^ "Case filed against three doctors over physician's death". New Age. Retrieved 2024-02-22.
  5. ^ Clinical Research Organization, Dhaka, Bangladesh (2012-12-11). "Phase IIII Study of a Therapeutic Vaccine Candidate Containing Hepatitis B Virus (HBV) Core Antigen (HBcAg) and HBV Surface Antigen (HBsAg) for Treatment of Patients With Chronic HBV Infection". ClinicalTrials.gov.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  6. ^ a b Al Mahtab, Mamun; Akbar, Sheikh Mohammad Fazle; Aguilar, Julio Cesar; Guillen, Gerardo; Penton, Euduaro; Tuero, Angela; Yoshida, Osamu; Hiasa, Yoichi; Onji, Morikazu (2018). "Treatment of chronic hepatitis B naïve patients with a therapeutic vaccine containing HBs and HBc antigens (a randomized, open and treatment controlled phase III clinical trial)". PLOS ONE. 13 (8): e0201236. Bibcode:2018PLoSO..1301236A. doi:10.1371/journal.pone.0201236. ISSN 1932-6203. PMC 6104936. PMID 30133478.
  7. ^ a b "Prof. Dr. Mamun Al Mahtab Shwapnil". Where's My Doctor?. 2024-01-09. Retrieved 2024-02-14.
  8. ^ "Prof Dr Mamun Al Mahtab Shwapnil - Appointment Process [Updated 2023]". 2022-01-27. Retrieved 2023-09-29.
  9. ^ "Dr Mamun Al Mahtab Shwapnil - Appointment Process [Updated 2023]". 2021-12-31. Retrieved 2023-09-29.
  10. ^ Al Mahtab, Mamun; Akbar, Sheikh Mohammad Fazle; Aguilar, Julio Cesar; Guillen, Gerardo; Penton, Euduaro; Tuero, Angela; Yoshida, Osamu; Hiasa, Yoichi; Onji, Morikazu (2018). "Treatment of chronic hepatitis B naïve patients with a therapeutic vaccine containing HBs and HBc antigens (a randomized, open and treatment controlled phase III clinical trial)". PLOS ONE. 13 (8): e0201236. Bibcode:2018PLoSO..1301236A. doi:10.1371/journal.pone.0201236. PMC 6104936. PMID 30133478.
  11. ^ Al Mahtab, M.; Akbar, S. M.; Aguilar, J. C.; Guillen, G.; Penton, E.; Tuero, A.; Yoshida, O.; Hiasa, Y.; Onji, M. (2018). "Treatment of chronic hepatitis B naïve patients with a therapeutic vaccine containing HBs and HBc antigens (a randomized, open and treatment controlled phase III clinical trial)". PLOS ONE. 13 (8): e0201236. Bibcode:2018PLoSO..1301236A. doi:10.1371/journal.pone.0201236. PMC 6104936. PMID 30133478.
  12. ^ "Bangladeshi researchers develop advanced drug for Hepatitis B". Dhaka Tribune. 2017-10-25.
  13. ^ Mahtab, M. A.; Rahman, S.; Karim, M. F.; Khan, M.; Foster, G.; Solaiman, S.; Afroz, S. (2008). "Europe PMC". Hepatobiliary & Pancreatic Diseases International. 7 (6): 595–600. PMID 19073404. Retrieved 2021-08-17.
  14. ^ "Medical conference dedicated to Bangabandhu begins today". bangladeshpost.net. Retrieved 2024-02-26.
  15. ^ Mahtab, Mamun-Al (2009-12-15). Liver: A Complete Book on Hepato-Pancreato-Biliary Diseases - E-Book. Elsevier Health Sciences. ISBN 978-81-312-3157-9.
  16. ^ Akbar, Sk. Md. Fazle; Kumar, Parveen June (30 November 2014). Mahtab, Mamun Al (ed.). Textbook of Hepato-Gastroenterology. Jaypee Brothers Medical Publishers Pvt. Limited. pp. https://www.google.com.bd/books/edition/Textbook_of_Hepato_Gastroenterology/zyjFoQEACAAJ?hl=en. ISBN 9789351523789.{{cite book}}: CS1 maint: date and year (link)
  17. ^ "EUROASIAN JOURNAL OF HEPATO-GASTROENTEROLOGY". Euroasian Journal of Hepato-Gastroenterology. 11.
  18. ^ "Hepatology International". Hepatology International. 15. 2024.
  19. ^ "Journal of Clinical and Experimental Hepatology". Journal of Clinical and Experimental Hepatology.
  20. ^ "Hepatitis B Annual".
  21. ^ "Association for the Study of Liver Diseases Bangladesh". asldb.
  22. ^ "Hepatology Alumni Association of BSMMU launched, Prof Swapnil president". bdnews24.
  23. ^ "Forum for the Study of the Liver Bangladesh". liverforum.
  24. ^ স্টেম সেল থেরাপি: সফল এক আবিষ্কার. sarabangla (in Bengali). 2017-12-26.
  25. ^ ঢাকায় অনুষ্ঠিত হল বিশ্বের প্রথম এন্ডোভাস্কুলোকন সম্মেলন. khobor71 (in Bengali).
  26. ^ "Sampriti Bangladesh meets Sri Lankan envoy, condemns bombing attacks". bdnews24.com. Retrieved 2021-08-17.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Mamun_Al_Mahtab&oldid=1258131363"